SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-028166
Filing Date
2021-05-17
Accepted
2021-05-17 07:10:54
Documents
75
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q alt-10q_20210331.htm 10-Q 1355361
2 EX-10.1 alt-ex101_6.htm EX-10.1 72151
3 EX-10.2 alt-ex102_226.htm EX-10.2 122303
4 EX-31.1 alt-ex311_11.htm EX-31.1 18167
5 EX-31.2 alt-ex312_10.htm EX-31.2 17900
6 EX-32.1 alt-ex321_7.htm EX-32.1 6182
7 EX-32.2 alt-ex322_9.htm EX-32.2 6136
8 GRAPHIC gkiizvlofxze000001.jpg GRAPHIC 45649
  Complete submission text file 0001564590-21-028166.txt   6132678

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT alt-20210331.xml EX-101.INS 1288067
10 XBRL TAXONOMY EXTENSION SCHEMA alt-20210331.xsd EX-101.SCH 51321
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alt-20210331_cal.xml EX-101.CAL 42336
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alt-20210331_def.xml EX-101.DEF 151365
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE alt-20210331_lab.xml EX-101.LAB 393623
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alt-20210331_pre.xml EX-101.PRE 292460
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32587 | Film No.: 21927519
SIC: 2834 Pharmaceutical Preparations